Bioyitech Wins "2025 Jung Innovation Award"! A Look at the Advancement of Micro-Ecology from a Fermented Carrot Juice!

On August 14th, the "2025 Food and Beverage Industry - Jung Innovation Award" ceremony was grandly held in Guangzhou. Bioyitech (Shanghai) Biotechnology Co., Ltd. won the "Innovative Product of the Year - Creative Health/Functional Beverage" award with its "Peike Probiotic Fermented Carrot Juice Drink," sharing the stage with well-known domestic companies such as Want Want and Junyao.

Technological Breakthrough: The "Postbiotic Code" in Carrot Juice

Relying on the symbiotic fermentation technology of lactic acid bacteria, "Peike Probiotic Fermented Carrot Juice" is a successful application of fermented fruits and vegetables + postbiotic drinks. It redefines the formula logic of fruit and vegetable juice with a single carrot:

*   0 sucrose, 0 essence, 0 preservatives, 0 artificial colors, nutritious and healthy;

*   Achieves a sweet taste solely relying on probiotics + concentrated carrot juice + Postbiotics;

*   A 12-month shelf life at room temperature, maintaining the freshness of the fruit and vegetable juice and extending product shelf-life stability through fermentation technology and postbiotic action.

It also breaks the application limitations of probiotics in the development of traditional fermented beverages—unaffected by temperature and environmental factors, eliminating the need for cold chain transportation and storage; unaffected by human gastric acid and bile, allowing effective and unobstructed direct delivery to the intestines; and simultaneously preserving the flavor substances of fermented fruits and vegetables and the functional metabolites of probiotics, acting in a more direct way in the intestines, making its fruity aroma long-lasting and its functionality not weakening with the extension of the shelf life, giving your taste buds and intestines a true SPA.

Behind this is Bioyitech's four-year construction of a "full-link research-production-clinical" system:

*   Jointly established the "Probiotic Joint Research Center for Special Food Purposes" with the Ocean University of China, with a strain library exceeding 6,000 strains, including 102 functional strains and postbiotics, focusing on sugar-lipid acid metabolism;

*   A 4,300㎡ pharmaceutical-grade factory, 5 fully automated production lines, billion-level high-density cell fermentation technology, automatic separation technology, emulsification and encapsulation technology, and all-angle thermal radiation micro-ice crystal freeze-drying technology, etc., improving the survival rate, stability, and fermentation activity of live bacteria by more than 50%, with a shelf life reaching the trillion-level level;

*   Through low-temperature directional enzymatic hydrolysis and microfiltration purification centrifugation technology, the functional metabolites of probiotics are preserved to the greatest extent while being inactivated;

*   Collaborated with the Second People's Hospital of Guangdong Province and the Second Affiliated Hospital of Zhejiang University School of Medicine to complete 6 clinical validations, including GLP-1 targeted strains and hyperuricemia strains.

Leveraging the strain resource library and evidence-based medicine, we've developed a system that integrates directional breeding, precise fermentation, and scenario-based applications. This process transforms probiotics like Lactiplantibacillus plantarum YZX21 and Lactiplantibacillus plantarum H-87, along with postbiotics, into verifiable, re-combinable, and sustainable micro-ecological solutions. These solutions are designed for the food, pharmaceutical, personal care, and animal/plant nutrition sectors.

While the industry is still competing on "the number of strains," Bioyitech has broken through the "limitations of probiotic application" and written "clinical evidence" into the product definition.

Scenario Breakthrough: Expanding the Diversified Application Scenarios of Probiotics

In the award speech, He Shumin, head of Bioyitech's South China region, clearly pointed out the company's development direction in concise language: "Focus on metabolism, prevent and treat diseases, and expand the diversified application scenarios of probiotics."

"Peike Probiotic Fermented Carrot Juice" is just a starting point.

*   On the B-side, the company provides ODM/OEM services for Bright Dairy, Synutra Group, and Hu Qingyu Tang, making probiotics into solid beverages, compressed candy, and postbiotic raw materials, further applying them to dairy products, health foods, daily chemicals, and animal and plant nutrition, and other scenarios;

*   On the C-side, it plans to support various outstanding influencers/anchors to launch new product plans, focusing on probiotic fermented fruit and vegetable juices, fermented tea drinks, and other aspects;

*   On the cross-border side, taking the company's GLP-1 targeted "Simei Bacteria" as the entry point, through the promotion of international exhibitions, it has realized the export of "Chinese bacteria" to the United States, Western Europe, and Southeast Asia.